{"id":9443,"date":"2023-11-04T04:33:07","date_gmt":"2023-11-04T04:33:07","guid":{"rendered":"https:\/\/infundpros.com\/news\/u-s-ipo-weekly-recap-biotech-lexeo-stumbles-after-100-million-ipo\/"},"modified":"2023-11-04T04:33:07","modified_gmt":"2023-11-04T04:33:07","slug":"u-s-ipo-weekly-recap-biotech-lexeo-stumbles-after-100-million-ipo","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=9443","title":{"rendered":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO"},"content":{"rendered":"<div data-test-id=\"content-container\">\n<p><figure class=\"getty-figure\" data-type=\"getty-image\"><picture>  <\/picture><figcaption> <\/figcaption><\/figure>\n<\/p>\n<p>After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which qualified for inclusion in our stats, while one deal was pushed back (SHIM<span class=\"paywall-full-content invisible\">). Four small Asia-based companies submitted initial filings.<\/span><\/p>\n<p class=\"paywall-full-content invisible\">In other notable news, reinsurer <strong>Hamilton Group<\/strong> (HG) launched its $255 million US IPO, with pricing slated for the week ahead. Healthcare billing platform <strong>Waystar<\/strong> (WAY), which was also eligible to launch this past week, is reportedly delaying its IPO until December at the earliest.<\/p>\n<p class=\"paywall-full-content invisible\">Biotech <strong>Lexeo Therapeutics<\/strong> (LXEO) priced at the low end to raise $100 million at a $282 million market cap. The company is focused on advancing in-licensed gene therapies for neurological and cardiovascular diseases. Its two lead candidates are currently being evaluated in Phase 1\/2 trials, with interim data from both<span class=\"paywall-full-content no-summary-bullets invisible\"> expected in mid to late 2024. Lexeo stumbled in its debut amid more challenging market conditions, finishing Friday down 9% from offer.<\/span><\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Hong Kong-based tech services provider <strong>Alpha Technology Group<\/strong> (ATGL) priced at the low end to raise $7 million at a $60 million market cap, and finished the week up 47%. While not included in the table below, Canadian mortgage broker <strong>Pineapple Financial<\/strong> (PAPL) priced at the low end to raise $4 million at a $29 million market cap, and finished down 54%.<\/p>\n<p> <span class=\"table-responsive paywall-full-content invisible no-summary-bullets\"><span class=\"table-scroll-wrapper\"><span data-intersection-boundary=\"start\"><\/span><\/p>\n<table>\n<thead>\n<tr>\n<th>2 IPOs During the Week of October 30th, 2023<\/th>\n<\/tr>\n<tr>\n<th>Issuer <em>Business<\/em> <\/th>\n<th>DealS ize<\/th>\n<th>Market Cap at IPO<\/th>\n<th>Price vs. Midpoint<\/th>\n<th>First Day Return<\/th>\n<th>Return at 11\/03<\/th>\n<\/tr>\n<\/thead>\n<tr>\n<td>Alpha Technology Group (ATGL)<\/td>\n<td>$7M<\/td>\n<td>$60M<\/td>\n<td>-11%<\/td>\n<td>+10%<\/td>\n<td>+47%<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><em>Provides software development and other services in Hong Kong.<\/em><\/td>\n<\/tr>\n<tr>\n<td>Lexeo Therapeutics (LXEO)<\/td>\n<td>$100M<\/td>\n<td>$282M<\/td>\n<td>-21%<\/td>\n<td>-9%<\/td>\n<td>-9%<\/td>\n<\/tr>\n<tr>\n<td colspan=\"6\"><em>Phase 1 biotech developing gene therapies for cardio and neuro diseases.<\/em><\/td>\n<\/tr>\n<\/table>\n<p> <span data-intersection-boundary=\"end\"><\/span><\/span><button class=\"table-enlarge-button\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 16 16\" class=\"table-enlarge-icon\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M16 11a5 5 0 0 1-5 5H5a5 5 0 0 1-5-5V5a5 5 0 0 1 5-5h6a5 5 0 0 1 5 5v6zm-4.5-2.5h2v-6h-6v2h4v4zm-9-1h2v4h4v2h-6v-6z\"><\/path><\/svg>Click to enlarge<\/button><\/span> <span class=\"table-responsive paywall-full-content invisible no-summary-bullets\"><span class=\"table-scroll-wrapper\"><span data-intersection-boundary=\"start\"><\/span><\/p>\n<table>\n<thead>\n<tr>\n<th>4 Filings During the Week of October 30th, 2023<\/th>\n<\/tr>\n<tr>\n<th>Issuer <em>Business<\/em> <\/th>\n<th>DealSize<\/th>\n<th>Sector<\/th>\n<th>Lead Underwriter<\/th>\n<\/tr>\n<\/thead>\n<tr>\n<td>Neo-Concept International (NCI)<\/td>\n<td>$9M<\/td>\n<td>Consumer Discretionary<\/td>\n<td>Revere Sec.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\"><em>Hong Kong-based apparel retailer and supply chain services provider.<\/em><\/td>\n<\/tr>\n<tr>\n<td>Ten-League International (TLIH)<\/td>\n<td>$32M<\/td>\n<td>Industrials<\/td>\n<td>Eddid Securities<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\"><em>Singapore-based provider of heavy equipment and engineering consultancy services.<\/em><\/td>\n<\/tr>\n<tr>\n<td>Baiya International (BIYA)<\/td>\n<td>$15M<\/td>\n<td>Industrials<\/td>\n<td>Revere Sec.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\"><em>Chinese HR platform that connects companies and blue-collar staffing agencies.<\/em><\/td>\n<\/tr>\n<tr>\n<td>BloomZ (BLMZ)<\/td>\n<td>$17M<\/td>\n<td>Communication Services<\/td>\n<td>Network 1<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\"><em>Japanese audio production and voice actor management company.<\/em><\/td>\n<\/tr>\n<\/table>\n<p> <span data-intersection-boundary=\"end\"><\/span><\/span><button class=\"table-enlarge-button\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 16 16\" class=\"table-enlarge-icon\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M16 11a5 5 0 0 1-5 5H5a5 5 0 0 1-5-5V5a5 5 0 0 1 5-5h6a5 5 0 0 1 5 5v6zm-4.5-2.5h2v-6h-6v2h4v4zm-9-1h2v4h4v2h-6v-6z\"><\/path><\/svg>Click to enlarge<\/button><\/span> <\/p>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"><strong>IPO Market Snapshot<\/strong><\/h2>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11\/2\/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&amp;P 500 was up 14.0%. Renaissance Capital&#8217;s IPO ETF (IPO) tracks the index, and top ETF holdings include Palantir Technologies (PLTR) and Kenvue (KVUE). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 4.3%. Renaissance Capital\u2019s International IPO ETF (IPOS) tracks the index, and top ETF holdings include Kuaishou and Porsche.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>Hamilton Group<\/strong> (HG) plans to raise $255 million at a $1.9 billion market cap. Mostly operating through subsidiaries in Bermuda and Europe, the company provides a range of insurance products globally, including casualty and specialty insurance, as well as reinsurance. Hamilton is set to be the year\u2019s third and largest insurance IPO; reinsurer Fidelis (FIHL) has hovered around its offer price since its June IPO, while fast-growing property &amp; casualty insurer Skyward (SKWD) has strongly outperformed since its early 2023 debut.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Holdover <strong>Shimmick <\/strong>(SHIM) is tentatively scheduled for the week ahead, aiming to raise $50 million at a $333 million market cap. The company specializes in public water infrastructure, including dams, reservoirs, water treatment, and desalination plans. Its project backlog is worth $1+ billion, though it is subject to cancellation and adjustments.<\/p>\n<p> <span class=\"table-responsive paywall-full-content invisible no-summary-bullets\"><span class=\"table-scroll-wrapper\"><span data-intersection-boundary=\"start\"><\/span><\/p>\n<table>\n<thead>\n<tr>\n<th>U.S. IPO Calendar<\/th>\n<\/tr>\n<tr>\n<th>Issuer Business<\/th>\n<th>Deal Size Market Cap<\/th>\n<th>Price Range Shares Filed<\/th>\n<th>Top Bookrunners<\/th>\n<\/tr>\n<\/thead>\n<tr>\n<td>Hamilton Group (HG) Hamilton, Bermuda<\/td>\n<td>$255M$1,923M<\/td>\n<td>$16 &#8211; $1815,000,000<\/td>\n<td>BarclaysMorgan Stanley<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\">Bermuda-based provider of reinsurance and specialty insurance.<\/td>\n<\/tr>\n<tr>\n<td>Shimmick (SHIM) Irvine, CA<\/td>\n<td>$50M$333M<\/td>\n<td>$10 &#8211; $124,550,000<\/td>\n<td>Roth Cap.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\">California-based construction firm specializing in public water infrastructure.<\/td>\n<\/tr>\n<\/table>\n<p> <span data-intersection-boundary=\"end\"><\/span><\/span><button class=\"table-enlarge-button\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 16 16\" class=\"table-enlarge-icon\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M16 11a5 5 0 0 1-5 5H5a5 5 0 0 1-5-5V5a5 5 0 0 1 5-5h6a5 5 0 0 1 5 5v6zm-4.5-2.5h2v-6h-6v2h4v4zm-9-1h2v4h4v2h-6v-6z\"><\/path><\/svg>Click to enlarge<\/button><\/span> <\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Street research is expected for five companies in the week ahead, and two lock-up periods will be expiring.<\/p>\n<h2 class=\"paywall-full-content invisible no-summary-bullets\"><strong>IPO Market Snapshot<\/strong><\/h2>\n<p class=\"paywall-full-content invisible no-summary-bullets\">The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11\/2\/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&amp;P 500 was up 14.0%. Renaissance Capital&#8217;s IPO ETF (IPO) tracks the index, and top ETF holdings include Palantir Technologies (PLTR) and Kenvue (KVUE). The Renaissance International IPO Index was down 22.4% year-to-date, while the ACWX was up 4.3%. Renaissance Capital\u2019s International IPO ETF (IPOS) tracks the index, and top ETF holdings include Kuaishou and Porsche.<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\">Original Post<\/p>\n<p class=\"paywall-full-content invisible no-summary-bullets\"><strong>Editor&#8217;s Note:<\/strong> The summary bullets for this article were chosen by Seeking Alpha editors.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4647484-us-ipo-weekly-recap-biotech-lexeo-stumbles-after-100-million-ipo?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":3920,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":{"0":"post-9443","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros<\/title>\n<meta name=\"description\" content=\"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=9443\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros\" \/>\n<meta property=\"og:description\" content=\"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=9443\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-04T04:33:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1697867249_image_1431384990.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=9443#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=9443\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO\",\"datePublished\":\"2023-11-04T04:33:07+00:00\",\"dateModified\":\"2023-11-04T04:33:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=9443\"},\"wordCount\":767,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=9443#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=9443\",\"url\":\"https:\/\/infundpros.com\/?p=9443\",\"name\":\"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2023-11-04T04:33:07+00:00\",\"dateModified\":\"2023-11-04T04:33:07+00:00\",\"description\":\"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=9443#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=9443\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=9443#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros","description":"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=9443","og_locale":"en_US","og_type":"article","og_title":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros","og_description":"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which","og_url":"https:\/\/infundpros.com\/?p=9443","og_site_name":"inFundPros","article_published_time":"2023-11-04T04:33:07+00:00","og_image":[{"width":1536,"height":1097,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1697867249_image_1431384990.jpg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=9443#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=9443"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO","datePublished":"2023-11-04T04:33:07+00:00","dateModified":"2023-11-04T04:33:07+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=9443"},"wordCount":767,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=9443#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=9443","url":"https:\/\/infundpros.com\/?p=9443","name":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2023-11-04T04:33:07+00:00","dateModified":"2023-11-04T04:33:07+00:00","description":"After ending October on shaky footing, the IPO market kicked off November with a fairly quiet week. Three new issuers began trading, two of which","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=9443#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=9443"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=9443#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO"}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9443"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9443\/revisions"}],"predecessor-version":[{"id":9444,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9443\/revisions\/9444"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/3920"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}